A study to establish the serological profile of Guillain-Barre syndrome following COVID-19
Candalija A. et al, (2021), JOURNAL OF THE PERIPHERAL NERVOUS SYSTEM, 26, 393 - 393
An In-vivo 1H-MRS short-echo time technique at 7T: Quantification of metabolites in chronic multiple sclerosis and neuromyelitis optica brain lesions and normal appearing brain tissue
Tackley G. et al, (2021), NeuroImage, 238, 118225 - 118225
An Optimized Treatment Protocol for Subretinal Injections Limits Intravitreal Vector Distribution.
Reichel FFL. et al, (2021), Ophthalmol Sci, 1
Asymptomatic carotid stenosis and stroke risk - Authors' reply.
Howard DPJ. and Rothwell PM., (2021), Lancet Neurol, 20
Baseline Cam or Pincer Morphology Is Associated with Loss of Quantitative Joint Space Width at the Hip: The Johnston County Osteoarthritis Project
Nelson A. et al, (2021), ARTHRITIS & RHEUMATOLOGY, 73, 427 - 428
Cerebral critical closing pressure and resistance-area product: the influence of dynamic cerebral autoregulation, age and sex.
Panerai RB. et al, (2021), Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism, 41, 2456 - 2469
Characterizing the cellular immune response to subretinal AAV gene therapy in the murine retina
Chandler LC. et al, (2021), Molecular Therapy - Methods & Clinical Development, 22, 52 - 65
Conformational dynamics of 13 amino acids long NSP11 of SARS-CoV-2 under membrane mimetics and different solvent conditions.
Gadhave K. et al, (2021), Microb Pathog, 158
Correction to: α-Synuclein in blood exosomes immunoprecipitated using neuronal and oligodendroglial markers distinguishes Parkinson’s disease from multiple system atrophy (Acta Neuropathologica, (2021), 142, 3, (495-511), 10.1007/s00401-021-02324-0)
Dutta S. et al, (2021), Acta Neuropathologica, 142
CSF extracellular vesicles and risk of disease activity after a first demyelinating event
Dalla Costa G. et al, (2021), Multiple Sclerosis Journal, 27, 1606 - 1610
Design of a randomised, double-blind, crossover, placebo-controlled trial of effects of sildenafil on cerebrovascular function in small vessel disease: Oxford haemodynamic adaptation to reduce pulsatility trial (OxHARP)
Webb A. et al, (2021), European Stroke Journal, 6, 283 - 290
Early detection of change in motor and cognitive symptoms in a longitudinal Progressive Supranuclear Palsy cohort - the OxQUIP study
Pereira M. and Antoniades C., (2021), MOVEMENT DISORDERS, 36, S254 - S254
Effect of Heeled Shoes on Joint Symptoms and Knee Osteoarthritis in Older Adults: A 5‐Year Follow‐Up Study
Perry TA. et al, (2021), ACR Open Rheumatology, 3, 614 - 621
Essential requirement for polypyrimidine tract binding proteins 1 and 3 in the maturation and maintenance of mature B cells in mice.
Monzón-Casanova E. et al, (2021), Eur J Immunol, 51, 2266 - 2273
GENERALIZED MYASTHENIA GRAVIS MANAGEMENT AND PRACTICE GUIDELINES: CROSS-SECTIONAL SURVEY OF COMMUNITY NEUROLOGISTS IN THE UNITED STATES
Bril V. et al, (2021), MUSCLE & NERVE, 64, S55 - S56
Genomic Insights into Myasthenia Gravis Identify Distinct Immunological Mechanisms in Early and Late Onset Disease
Handunnetthi L. et al, (2021), Annals of Neurology, 90, 455 - 463
Global proteomic analysis of extracellular matrix in mouse and human brain highlights relevance to cerebrovascular disease.
Pokhilko A. et al, (2021), J Cereb Blood Flow Metab, 41, 2423 - 2438
Guillain-Barre syndrome following SARS-CoV-2 infection in the international GBS outcome study
Luijten L. et al, (2021), JOURNAL OF THE PERIPHERAL NERVOUS SYSTEM, 26, 372 - 373
Identifying sex-specific differences in the carotid revascularisation literature: findings from a scoping review.
Yogendrakumar V. et al, (2021), Stroke and vascular neurology, 6, 496 - 499